Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disorder in which a mutation in the PIGA gene causes red blood cells to lack critical surface proteins (CD55 and CD59). Without these protective anchors, the complement system—a part of our innate immunity—attacks and destroys red blood cells within blood vessels, leading to chronic intravascular hemolysis, fatigue, dark urine, and life-threatening blood clots Wikipedia. PNH can occur at any age but most often presents in young adults and, if untreated, carries significant risks of anemia, thrombosis, and organ damage MedlinePlus.

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disorder in which a mutation in the PIGA gene causes red blood cells (and to a lesser extent white blood cells and platelets) to lack protective surface proteins. Without these glycosylphosphatidylinositol (GPI)-anchored regulators—most notably CD55 and CD59—compliment proteins attack and destroy red blood cells within blood vessels, leading to chronic intravascular hemolysis Wikipedia. Over time, this process releases free hemoglobin into the plasma, depletes haptoglobin, and consumes nitric oxide, which can trigger smooth muscle spasms, fatigue, and an elevated risk of life-threatening blood clots Cleveland Clinic.

Types of Paroxysmal Nocturnal Hemoglobinuria

PNH is classified by the clinical context in which it arises:

• Classic PNH: Evidence of a PNH clone without any other bone marrow disorder. Patients typically present with hemolysis and symptoms such as dark urine. Wikipedia

• PNH with another bone marrow disorder: PNH occurring alongside conditions like aplastic anemia or myelodysplastic syndrome (MDS). Here, hemolysis may be accompanied by low blood counts due to marrow failure Wikipedia.

• Subclinical PNH: Small PNH clones detected on flow cytometry without overt hemolysis or clinical symptoms. These patients may remain stable for years. Wikipedia

Causes of Paroxysmal Nocturnal Hemoglobinuria

While the single unifying cause of PNH is a somatic mutation in the PIGA gene within a hematopoietic stem cell, several factors contribute to disease emergence and progression:

1. Somatic PIGA gene mutation: A spontaneous change in the PIGA gene on the X chromosome prevents GPI‐anchor formation, removing protective proteins from cell surfaces Cleveland Clinic.

2. GPI‐anchor synthesis defect: Without PIGA, GPI anchors cannot attach regulators like CD55 and CD59 to blood cells, exposing them to complement attack Wikipedia.

3. Loss of CD55 (decay-accelerating factor): Normally disrupts complement C3 convertase; its absence accelerates complement-mediated damage Wikipedia.

4. Loss of CD59 (protectin): Prevents formation of the membrane attack complex; deficiency permits uncontrolled cell lysis Wikipedia.

5. Complement system activation: Without GPI-anchored inhibitors, the complement cascade proceeds unchecked against red cells Wikipedia.

6. Membrane attack complex formation: Leads directly to intravascular hemolysis Wikipedia.

7. Intravascular hemolysis: Releases free hemoglobin and other cell contents into the bloodstream Wikipedia.

8. Haptoglobin depletion: Free hemoglobin binds and exhausts haptoglobin, a key scavenger protein Wikipedia.

9. Nitric oxide scavenging: Free hemoglobin binds nitric oxide, reducing its availability and causing smooth muscle spasm Cleveland Clinic.

10. Smooth muscle dystonias: Spasms in the gastrointestinal tract, esophagus, or erectile tissue result from nitric oxide loss Wikipedia.

11. Platelet activation: Cumulative complement damage to platelets creates a prothrombotic state Cleveland Clinic.

12. Association with aplastic anemia: Many PNH cases emerge in the setting of immune-mediated marrow failure Cleveland Clinic.

13. Association with myelodysplastic syndrome (MDS): Clonal overlap can lead to PNH features Cleveland Clinic.

14. Association with acute myelogenous leukemia (AML): Rarely, PNH may present alongside or after AML Verywell Health.

15. Pregnancy: Immune modulation and hypercoagulability in pregnancy can unmask PNH Wikipedia.

16. Nocturnal acidification hypothesis: Relative hypoventilation at night may increase hemolysis in early disease Wikipedia.

17. Illness and infections: Triggers such as infections can precipitate hemolytic episodes Verywell Health.

18. Physical or emotional stress: Stressful events may exacerbate complement activation Verywell Health.

19. Idiopathic cases: In many patients, no additional precipitant beyond the PIGA mutation is identified Autoimmune Association.

20. Secondary genetic or immune factors: Researchers suggest other mutations or immune alterations may favor PNH clone expansion National Organization for Rare Disorders.

Symptoms of Paroxysmal Nocturnal Hemoglobinuria

Patients with PNH experience a broad spectrum of signs and symptoms, often in overlapping categories:

1. Hemoglobinuria (dark urine): Red-brown urine most noticeable in the morning trips to the bathroom Cleveland Clinic.

2. Chronic hemolytic anemia: Manifests as fatigue, weakness, and pallor Cleveland Clinic.

3. Shortness of breath (dyspnea): Occurs especially on exertion due to reduced oxygen-carrying capacity Cleveland Clinic.

4. Palpitations: Rapid heartbeat from anemia-induced high-output state Wikipedia.

5. Abdominal pain: Smooth muscle spasms or hepatic vein thrombosis (Budd-Chiari syndrome) Wikipedia.

6. Difficulty swallowing (dysphagia): Esophageal spasm from nitric oxide depletion Wikipedia.

7. Painful swallowing (odynophagia): Related to esophageal muscle spasm Wikipedia.

8. Esophageal spasms: Causes chest discomfort and dysphagia Cleveland Clinic.

9. Back pain: Smooth muscle involvement or referred pain Cleveland Clinic.

10. Kidney dysfunction: Chronic hemoglobinuria damages renal tubules Cleveland Clinic.

11. Thrombosis: Venous blood clots are a leading cause of mortality Cleveland Clinic.

12. Deep vein thrombosis (DVT): Painful, swollen leg veins Wikipedia.

13. Pulmonary embolism: Sudden chest pain and dyspnea when clots travel to lungs Wikipedia.

14. Hepatic vein thrombosis (Budd-Chiari syndrome): Abdominal pain, ascites, and liver enlargement Wikipedia.

15. Cerebral venous thrombosis: Headache, visual disturbances, or stroke-like symptoms Wikipedia.

Further Diagnostic Tests

Below are 20 key tests, grouped by category, used to confirm PNH and evaluate its complications:

Physical Examination

1. General physical exam: Look for pallor, jaundice, or signs of anemia and thrombosis MedlinePlus.

2. Abdominal exam: Assess liver size and for ascites in suspected Budd-Chiari syndrome Wikipedia.

3. Skin exam: Inspect for superficial vein engorgement or petechiae from thrombosis Wikipedia.

4. Neurological exam: Evaluate focal deficits suggesting cerebral vein thrombosis Wikipedia.

Manual (Functional) Tests

1. Sucrose lysis test: Screening test that exploits low-ionic-strength solutions to trigger complement lysis in PNH cells Wikipedia.
2. Ham’s acid hemolysis test: Confirms PNH by demonstrating acid-mediated complement activation on RBCs Wikipedia.
3. Direct antiglobulin (Coombs) test: Typically negative in PNH, helping distinguish it from autoimmune hemolysis Wikipedia.
4. Sugar water test: A point-of-care version of the sucrose lysis assay for rapid screening Wikipedia.

Laboratory and Pathological Tests

1. Complete blood count (CBC): Reveals anemia, leukopenia, or thrombocytopenia Cleveland Clinic.
2. Reticulocyte count: Elevated in response to hemolysis Cleveland Clinic.
3. Lactate dehydrogenase (LDH): High levels indicate active intravascular hemolysis Cleveland Clinic.
4. Bilirubin (indirect): Elevated with hemoglobin breakdown Cleveland Clinic.
5. Haptoglobin: Low in intravascular hemolysis as it binds free hemoglobin Cleveland Clinic.
6. Urinalysis: Detects hemoglobinuria and hemosiderinuria Cleveland Clinic.
7. Flow cytometry (CD55/CD59): Gold standard to quantify GPI-deficient cell populations Wikipedia.
8. FLAER assay: Uses fluorescent aerolysin to sensitively detect GPI anchor deficiency Wikipedia.

Electrodiagnostic Tests

1. Electrocardiogram (ECG): Identifies tachycardia or arrhythmias in severe anemia PMC.
2. Holter monitor: Continuous ECG monitoring for intermittent palpitations The Lancet.

Imaging Tests

1. Doppler ultrasound of limbs: Detects deep vein thrombosis in patients with swelling or pain NCBI.
2. Abdominal ultrasound: Evaluates hepatic vein patency and ascites for Budd-Chiari syndrome American Journal of Roentgenology.

Non-Pharmacological Treatments

1. Packed Red Blood Cell Transfusions
   Regular transfusions of packed red blood cells help raise hemoglobin levels, relieve anemia symptoms, and suppress the overproduction of defective PNH cells in bone marrow Cleveland Clinic.

2. Platelet Transfusions
   When PNH leads to dangerously low platelet counts, targeted platelet transfusions support clotting function and reduce bleeding risk Rare Disease Advisor.

3. Hydration Therapy
   Maintaining good hydration dilutes blood, lessens hemolysis, and helps prevent formation of small clots in the microcirculation Cleveland Clinic.

4. Supplemental Oxygen
   Low-flow oxygen for patients with severe anemia eases shortness of breath and improves tissue oxygenation Cleveland Clinic.

5. Iron Supplementation
   Oral or intravenous iron corrects iron depletion from chronic hemoglobinuria, supporting new red blood cell production PMC.

6. Folic Acid Supplementation
   Daily folic acid (1 mg) supports rapid red blood cell synthesis in the marrow, counteracting the increased demand caused by hemolysis PMC.

7. Vitamin B₁₂ Supplementation
   Vitamin B₁₂ (1,000 µg monthly) prevents megaloblastic changes and further supports healthy erythropoiesis PMC.

8. Nutritional Counseling
   A dietitian-guided plan ensures adequate protein, vitamins, and minerals to bolster overall blood health and energy levels Cleveland Clinic.

9. Occupational Therapy
   Customized activity plans help patients conserve energy, manage fatigue, and maintain daily function Rare Disease Advisor.

10. Physical Therapy
    Mild, regular exercise under guidance improves muscle strength, enhances circulation, and reduces fatigue without triggering hemolytic crises Rare Disease Advisor.

11. Psychological Support
    Counseling and stress-management techniques mitigate anxiety and depression, common in chronic illnesses Rare Disease Advisor.

12. Stress Management Techniques
    Mindfulness, meditation, and biofeedback lower stress hormones that can precipitate hemolytic attacks Rare Disease Advisor.

13. Sleep Hygiene Improvement
    Regular sleep schedules and good sleep practices improve resilience against fatigue and help regulate immune function Rare Disease Advisor.

14. Infection Prevention Measures
    Hand hygiene, mask use, and up-to-date vaccinations (influenza, pneumococcal, meningococcal) reduce infection-triggered hemolysis Cleveland Clinic.

15. Thermoregulation
    Avoiding extreme heat or cold helps prevent complement activation on red blood cells Rare Disease Advisor.

16. Avoidance of Dehydration
    Regular fluid intake helps maintain blood volume and reduces hemolytic events Cleveland Clinic.

17. Compression Stockings
    Graduated compression stockings support venous return, lowering the risk of deep vein thrombosis Rare Disease Advisor.

18. Medical Alert Identification
    Wearing a medical ID bracelet informs healthcare providers of PNH in emergencies, ensuring rapid, appropriate care Rare Disease Advisor.

19. Heat-Avoidance Strategies
    Cooling vests or air-conditioned environments prevent temperature-induced hemolysis Rare Disease Advisor.

20. Patient Education and Support Groups
    Learning self-management skills and sharing experiences in support groups improves coping, adherence, and quality of life Rare Disease Advisor.

Pharmacological Treatments

1. Eculizumab (C5 inhibitor)
   • Dosage: 600 mg IV weekly for 4 weeks, then 900 mg IV every 2 weeks
   • Drug Class: Monoclonal antibody (complement inhibitor)
   • Timing: Infusions in a specialized center
   • Side Effects: Headache, upper respiratory infections, meningococcal infection risk Wikipediapnh.iamrare.org.

2. Ravulizumab (Long-acting C5 inhibitor)
   • Dosage: 1,000 mg IV every 8 weeks (weight-based)
   • Class: Monoclonal antibody
   • Timing: Bi-monthly infusions
   • Side Effects: Similar to eculizumab, but reduced infusion frequency Apellis.

3. Pegcetacoplan (C3 inhibitor)
   • Dosage: 1,080 mg subcutaneously twice weekly
   • Class: Peptide inhibitor
   • Timing: Self-administered injections
   • Side Effects: Injection site reactions, infections Cleveland Clinic.

4. Crovalimab (C5 inhibitor)
   • Dosage: Loading dose followed by 800 mg SC every 4 weeks
   • Class: Monoclonal antibody
   • Timing: Monthly injections
   • Side Effects: Headache, infection risk Apellis.

5. Danicopan (Factor D inhibitor)
   • Dosage: 100 mg orally three times daily
   • Class: Small-molecule complement inhibitor
   • Timing: TID with meals
   • Side Effects: Abdominal pain, nausea Apellis.

6. Iptacopan (Factor B inhibitor)
   • Dosage: 200 mg orally twice daily
   • Class: Small molecule
   • Timing: BID
   • Side Effects: Headache, diarrhea Apellis.

7. Prednisone (Corticosteroid)
   • Dosage: 0.5–1 mg/kg/day orally during hemolytic crises
   • Class: Glucocorticoid
   • Timing: Daily taper
   • Side Effects: Weight gain, osteoporosis, infection risk Rare Disease Advisor.

8. Warfarin (Anticoagulant)
   • Dosage: INR target 2–3, typically 1–5 mg daily
   • Class: Vitamin K antagonist
   • Timing: Daily oral dosing
   • Side Effects: Bleeding, requires INR monitoring Wikipedia.

9. Enoxaparin (Low-molecular-weight heparin)
   • Dosage: 1 mg/kg SC every 12 hours
   • Class: Anticoagulant
   • Timing: BID injections
   • Side Effects: Bleeding, thrombocytopenia Wikipedia.

10. Tranexamic Acid (Antifibrinolytic)
    • Dosage: 1,000 mg orally three times daily
    • Class: Antifibrinolytic
    • Timing: TID
    • Side Effects: Nausea, risk of thrombosis Dr.Oracle.

Dietary Molecular Supplements

1. Folic Acid (1 mg daily)
   Supports DNA synthesis in red blood cell precursors and helps prevent neural tube defects in pregnancy PMC.

2. Vitamin B₁₂ (1,000 µg monthly)
   Prevents megaloblastic anemia by aiding DNA replication in marrow cells PMC.

3. Iron (Ferrous Sulfate) (65 mg elemental iron daily)
   Replenishes iron stores lost through chronic hemoglobinuria, enabling hemoglobin production PMC.

4. Vitamin C (500 mg daily)
   Enhances oral iron absorption and acts as an antioxidant to reduce oxidative stress on red cells.

5. Vitamin E (400 IU daily)
   Protects cell membranes from oxidative hemolysis.

6. Omega-3 Fatty Acids (1 g EPA/DHA daily)
   Lowers inflammation and may reduce complement activation.

7. Curcumin (500 mg twice daily)
   Exhibits anti-inflammatory and antioxidant effects on blood vessels.

8. Coenzyme Q₁₀ (100 mg daily)
   Supports mitochondrial function and reduces oxidative damage.

9. N-Acetyl Cysteine (600 mg twice daily)
   Boosts glutathione levels in red blood cells, countering oxidative hemolysis.

10. Zinc (25 mg daily)
    Supports immune function and may stabilize red blood cell membranes.

Regenerative and Stem Cell–Related Agents

1. Filgrastim (G-CSF, 5 µg/kg SC daily)
   Stimulates neutrophil production to protect against infection and support marrow health.

2. Pegfilgrastim (6 mg SC once per chemotherapy cycle)
   Long-acting G-CSF that sustains neutrophil counts with a single dose.

3. Sargramostim (GM-CSF, 250 µg/m² SC daily)
   Promotes growth of multiple blood cell lines during marrow recovery.

4. Epoetin Alfa (50–150 IU/kg SC three times weekly)
   Encourages red blood cell formation in anemia associated with marrow stress.

5. Darbepoetin Alfa (2.25 µg/kg SC weekly)
   Longer-acting erythropoiesis-stimulating agent reducing injection frequency.

6. Romiplostim (1–10 µg/kg SC weekly)
   Thrombopoietin receptor agonist that boosts platelet counts in thrombocytopenia.

Surgical and Interventional Procedures

1. Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
   Curative bone marrow replacement from a matched donor; indicated for severe, refractory PNH Merck Manuals.

2. Splenectomy
   Removal of the spleen to reduce hemolysis and transfusion needs when supportive care fails Merck Manuals.

3. Cholecystectomy
   Gallbladder removal to treat gallstones from chronic hemolysis Merck Manuals.

4. Liver Transplantation
   For liver failure due to Budd-Chiari syndrome (hepatic vein thrombosis) Rare Disease Advisor.

5. Transjugular Intrahepatic Portosystemic Shunt (TIPS)
   Radiologic creation of a portal-systemic channel to relieve portal hypertension in Budd-Chiari Rare Disease Advisor.

6. Hepatic Vein Thrombectomy
   Surgical removal of clots from hepatic veins to restore hepatic blood flow Rare Disease Advisor.

7. Portal Vein Thrombectomy
   Clearing clots in portal circulation to treat portal vein thrombosis Rare Disease Advisor.

8. Hepatic Vein Angioplasty and Stenting
   Balloon dilation and stent placement in stenosed hepatic veins to improve outflow Rare Disease Advisor.

9. Splenic Artery Embolization
   Minimally invasive blockage of splenic blood supply to reduce hemolysis without full splenectomy Rare Disease Advisor.

10. Inferior Vena Cava (IVC) Filter Placement
    Prevents pulmonary embolism in patients with recurrent deep vein thrombosis Rare Disease Advisor.

Preventive Strategies

• Maintain up-to-date vaccinations against encapsulated organisms (meningococcus, pneumococcus, Haemophilus influenzae).

• Stay well hydrated to dilute complement activity in blood.

• Avoid smoking and excessive alcohol, which can stress red blood cells.

• Practice good hand hygiene and infection control to prevent hemolytic triggers.

• Use compression stockings during long travel to lower clot risk.

• Employ stress-reduction techniques to prevent symptom flares.

• Wear medical ID to alert providers to PNH in emergencies.

• Avoid extreme temperatures that can enhance complement activity.

• Schedule regular medical follow-up and lab tests every 3–6 months.

• Educate family and caregivers about emergency signs and basic PNH care Merck Manuals.

When to See a Doctor

Seek prompt medical attention if you experience:

• Dark or red-tinged urine, especially upon waking.

• Sudden severe fatigue, dizziness, or chest pain.

• New or worsening abdominal pain, headache, or swelling in arms/legs.

• Shortness of breath at rest or with minimal exertion.

• Signs of bleeding (gum bleeding, easy bruising).

• Fever or signs of infection.

• Unexplained weight loss or night sweats.

• Symptoms of clotting (sudden limb pain, redness, warmth).

• Yellowing of skin or eyes (jaundice).

• Any change suggesting anemia or thrombosis Cleveland Clinic.

Dietary Recommendations

Foods to Include:

• Leafy Greens & Legumes: Rich in folate and iron to support red cell production.

• Lean Meats & Fish: Provide easily absorbed heme iron and protein for marrow health.

• Dairy & Eggs: Excellent sources of vitamin B₁₂ for DNA synthesis.

• Berries & Nuts: Packed with antioxidants (vitamin C, E, and zinc) to protect red blood cells.

• Whole Grains: Supply B-vitamins and fiber for sustained energy and gut health.

Foods to Avoid:

• Alcohol & Caffeine: Can dehydrate you and worsen hemolysis.

• High-Sugar Processed Foods: Promote inflammation and fatigue.

• Excess Salt & Saturated Fats: Increase blood pressure and cardiovascular stress.

• Raw or Undercooked Meats: Heightened infection risk in immunocompromised states.

• Very High-Oxalate Foods (e.g., spinach smoothies): Can impair mineral absorption when consumed in excess.

Frequently Asked Questions (FAQs)

1. What causes PNH?
   PNH arises when a mutation in the PIGA gene of a bone marrow stem cell prevents formation of GPI anchors. Without GPI-anchored proteins, red blood cells become vulnerable to complement attack Merck Manuals.

2. Is PNH inherited?
   No. PNH is acquired, not passed down in families. It results from a spontaneous mutation in a blood stem cell during one’s lifetime MedlinePlus.

3. Can PNH be cured?
   Allogeneic stem cell transplant offers a potential cure but carries high risks. Most patients manage PNH long-term with complement inhibitors and supportive care Merck Manuals.

4. How is PNH diagnosed?
   Flow cytometry testing for CD55 and CD59 on blood cells is the gold standard, often complemented by lactate dehydrogenase and haptoglobin levels Wikipedia.

5. Why is urine dark in PNH?
   When red blood cells break down in vessels, free hemoglobin is filtered into the urine, causing a red-brown or dark color, especially in the morning Wikipedia.

6. What are the main treatment options?
   Eculizumab and ravulizumab (complement inhibitors) drastically reduce hemolysis, transfusion needs, and thrombosis risk. Supportive transfusions and supplements address anemia pnh.iamrare.org.

7. Are there side effects to complement inhibitors?
   Yes—most notably an increased risk of meningococcal infection, so vaccination and vigilant monitoring are mandatory Wikipedia.

8. Can I drink alcohol with PNH?
   Alcohol can dehydrate you and trigger hemolysis, so moderation or avoidance is strongly recommended Cleveland Clinic.

9. How often should I have lab tests?
   Generally every 3–6 months for blood counts, LDH, and flow cytometry to monitor clone size and treatment response HTC.

10. Is pregnancy safe with PNH?
    Pregnancy increases thrombosis risk; close monitoring, anticoagulation, and complement inhibitor use can improve outcomes ASH Publications.

11. What if I miss a dose of my medication?
    Contact your healthcare provider immediately—missing doses of complement inhibitors can lead to breakthrough hemolysis and clotting.

12. Can I exercise with PNH?
    Light to moderate exercise is beneficial for circulation and stamina, but avoid strenuous activity that may trigger hemolytic crises Rare Disease Advisor.

13. Do I need to avoid vaccinations?
    No—vaccines against encapsulated bacteria are crucial. Avoid live vaccines if you’re on heavy immunosuppression.

14. What is the life expectancy with PNH?
    With modern treatments like eculizumab, life expectancy approaches that of the general population, though lifelong monitoring remains essential.

15. Where can I find support?
    Patient organizations (e.g., PNH Research and Support Foundation) and local support groups offer resources, mentoring, and the latest research updates.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 26, 2025.